Miromatrix Medical Inc. (NASDAQ:MIRO) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET

Company Participants

Hannah Jeffrey - Gilmartin Group LLC

Jeff Ross - CEO

Jim Douglas - CFO

Conference Call Participants

Alex Nowak - Craig-Hallum Capital

Operator

Greetings and welcome to Miromatrix Medical Inc.’s First Quarter 2022 Earnings Conference Call. At this time all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

I would now like to turn this conference over to your host, Ms. Hannah Jeffrey from Gilmartin. Thank you. Ma'am you may begin your presentation at this time.

Hannah Jeffrey

Good afternoon. And thank you for joining us today. Earlier today, Miromatrix released financial results for the quarter ended March 31, 2022. The release is currently available on the Company's website at www.miromatrix.com. Jeff Ross, Chief Executive Officer; and Jim Douglas, Chief Financial Officer will host this afternoon's call.

Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that are not statements of historical facts, including statements regarding the potential timing of the filing of the IND application for MiroliverELAP and the initiation of the related clinical trial, should be deemed to be forward-looking statements. All forward-looking statements are based upon current estimates and various assumptions.

These statements involve material risks and uncertainties that could cause actual results to differ materially from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a list and descriptions of material risks and uncertainties associated with our business, please see our filings with the Securities and Exchange Commission.

The information provided in this conference call speaks only to the live broadcast today May, 16, 2022. Miromatrix disclaims any intention or obligation, except as required by law to update or revise any information, financial projections, or other forward-looking statements, whether because of new information, future events, or otherwise.

I will now turn the call over to Jeff.

Jeff Ross

Thanks, Hannah. Good afternoon. And thank you to everyone who has joined us today for our first quarter 2022 earnings call. Today, I'll start with a brief overview of Miromatrix to remind everyone of our positioning and differentiation, followed by a business update from our first quarter before turning the call over to our CFO, Jim Douglas, for a financial review.